[F-18]-FLUDEOXYGLUCOSE (FDG) INJECTION
Google image searchProduct monograph
Active ingredient
fludeoxyglucose 18f, 441 GBQ/VIAL
DIN: 02460734
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Schedule C
Company: SYLVIA FEDORUK CANADIAN CENTRE FOR NUCLEAR INNOVATION
Date: 16-OCT-2019
ATC:
- V09 — DIAGNOSTIC RADIOPHARMACEUTICALS (ATC, ATC/DDD, )
- V09I — TUMOUR DETECTION (ATC, ATC/DDD)
- V09IX — Other diagnostic radiopharmaceuticals for tumour detection (ATC, ATC/DDD)
- V09IX04 — FLUDEOXYGLUCOSE (18F) (ATC/DDD)
